Sun, Jul 13, 2014, 2:44 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Curis, Inc. Message Board

forgetme22 7 posts  |  Last Activity: Jul 10, 2014 12:21 AM Member since: May 6, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    5 sponsors / 5 drugs /

    by fda_approval_trading Jun 6, 2014 5:23 PM
    forgetme22 forgetme22 Jul 10, 2014 12:21 AM Flag

    From salix presentation today, adcom will be on this friday! U can download the presentaion from the salix website!

  • SYMPOSIUM 18

    08.00-09.30 HALL 2

    Late Breaking Clinical Trials 2

    Chairs: Peter J. Blankestijn, Utrecht, The Netherlands
    Vladimir Tesar, Prague, Czech Republic

    Impact of parathyroidectomy and cinacalcet use on survival in chronic hemodialysis patients: the COSMOS study
    Jorge B. Cannata-Andía, Oviedo, Spain
    Investigation of serious adverse events in bardoxolone methyl patients in BEACON
    Colin Meyer, Irving, USA
    High serum calcification propensity is associated with mortality and graft failure in renal transplant recipients
    Charlotte Keyzer, Groningen, The Netherlands
    A double-blind placebo controlled randomized trial of ferric citrate coordination complex for the treatment of iron-deficiency anemia and reduction of serum phosphate in patients with non-dialysis dependent chronic kidney disease
    Geoffrey Block, Denver, USA
    Diagnosis and prediction of progression of chronic kidney disease by assessment of urinary peptides
    Harald Mischak, Hannover, Germany

    back to the timetable

  • forgetme22 by forgetme22 May 10, 2014 5:55 PM Flag

    This cmc issues iare not unique to kerx!

    "Yes, it’s the same supplier. And as I said before, we do not believe that this is plant related. I know that’s an issue that’s come up recently with some other companies."

  • Reply to

    new job posted yesterday

    by forgetme22 May 7, 2014 1:34 AM
    forgetme22 forgetme22 May 7, 2014 1:44 AM Flag

    description
    Desired Skills and Experience
    The successful candidate will be a financial professional with at least 6 years of experience and progressive career growth within a life sciences business where commercial acumen is valued. It is essential that candidates combine world-class financial expertise with a “roll-up-your-sleeves” mindset. While able to manage through a team, qualified candidates must be front and center in driving results. The person in this role must be able to partner successfully across functional areas throughout the company, while maintaining a strong financial focus on behalf of Keryx.

    Additional experience and qualifications will include:

    Proven ability and experience calculating gross revenue to net revenue.

    Deep understanding of healthcare reimbursement models.

    Able to effectively influence people of all levels to drive change and improvement.

    Track record of applying strong analytical skills – including commercial, financial acumen and budget management – to enhance decision-making.

    The ability to lead change and work well within an innovative and performance driven environment.

    Decision making and communication skills that have been honed in dynamic environments where change must be anticipated rather than reacted to.

    Strong ability to review and identify issues and opportunities in the business and get things done.

    Flexibility in thinking and pragmatic problem solving skills.

    Strong alignment with the business focus on customer needs to drive decisions.
    Bachelor’s Degree in Finance or Accounting. CPA and/or MBA preferred.

  • Associate Director, Financial Planning & Analysis
    Keryx Biopharmaceuticals - Boston, MA
    Posted 9 hours ago
    Apply nowSave
    Other Details
    About this job
    Job description
    This position will play a key role in providing executive management with meaningful and insightful financial analysis related to business operations, new growth opportunities as well as existing performance trends against operating plans.
    This role will report directly into the Executive Director, Financial Planning & Analysis with responsibility for developing the annual budget process, including analysis and forecasting.
    He/She will act as the analytical engine of the company and will be expected to uncover valuable insights and provide well-rounded analyses that drive ‘optimal’ strategic decisions and further promote the overall performance of the business.

  • forgetme22 by forgetme22 Apr 16, 2014 11:33 PM Flag

    2-4 tablet a day depends on phosphorus level of the pt. So it costs 5 to 10 dollars a day.
    Ferric citrate cost 6 to 24 dollars a day! Wow we are goiing to be rich!!!

  • forgetme22 by forgetme22 Apr 16, 2014 11:15 PM Flag

    Sevelamer (Germany, United States)
    Renagel 800 mg tablet $ 2.41 Renvela
    800 mg tablet $ 2.17
    Renagel 400 mg tablet $ 1.66

    Sentiment: Buy

CRIS
1.83+0.14(+8.28%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Turtle Beach Corporation
NasdaqGMFri, Jul 11, 2014 4:00 PM EDT